approval · primary record
BREXANOLONE
FDA · NDA · 2025-01-23
| Agency | FDA |
|---|---|
| Submission type | NDA |
| Action date | 2025-01-23 |
| Brand | ZULRESSO |
| Sponsor | SAGE THERAP SUPERNUS |
| Route | INTRAVENOUS |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T10:38:34.851Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:BREXANOLONE:2025-01-23
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Brexanolone · compound